Nevro Enters Into Cooperation Agreement With Engaged Capital

Go back to Nevro Enters Into Cooperation Agreement With Engaged Capital

Oppenheimer Downgrades Nevro Corp (NVRO) to Perform, 'unclear path to material growth'

February 22, 2024 6:51 AM EST

Oppenheimer analyst Suraj Kalia downgraded Nevro Corp (NYSE: NVRO) from Outperform to Perform.

The analyst comments "4Q23 revs in line with pre-release ($116M). PDN contribution of $22.4M (+29% y/y, ~+8% seq.). Continued weakness in core SCS (-3% y/y). Ex-PDN, core US SCS... More